StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their target price on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Check Out Our Latest Report on Veradigm
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- The Significance of Brokerage Rankings in Stock Selection
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- 3 Healthcare Dividend Stocks to Buy
- 5 Best Gold ETFs for March to Curb Recession Fears
- Profitably Trade Stocks at 52-Week Highs
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
